BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29953791)

  • 1. Clinical evaluation of MRI in the differential diagnosis between benign and malignant ovarian tumors.
    Zhang T; Yi X; Lu J; Fu A
    Eur J Gynaecol Oncol; 2017; 38(2):257-262. PubMed ID: 29953791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
    Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
    Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.
    Li X; Hu JL; Zhu LM; Sun XH; Sheng HQ; Zhai N; Hu XB; Sun CR; Zhao B
    Tumour Biol; 2015 Jul; 36(7):5515-22. PubMed ID: 25724182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
    Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
    J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
    Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
    Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Borderline Epithelial Ovarian Tumors from Benign and Malignant Epithelial Ovarian Tumors by MRI Scoring.
    Babaoglu S; Atas AE; Kerimoglu U; Iyisoy MS; Kilinc F
    Curr Med Imaging; 2024; 20():e060623217706. PubMed ID: 37282660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sonographically indeterminate ovarian tumors with MR imaging. A logistic regression analysis.
    Yamashita Y; Hatanaka Y; Torashima M; Takahashi M; Miyazaki K; Okamura H
    Acta Radiol; 1997 Jul; 38(4 Pt 1):572-7. PubMed ID: 9240680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
    Marcos HB; Semelka RC
    J Magn Reson Imaging; 1999 Dec; 10(6):950-60. PubMed ID: 10581508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm).
    Park SY; Oh YT; Jung DC
    Acta Radiol; 2016 May; 57(5):633-9. PubMed ID: 26231948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Saida T; Oki A; Yoshikawa H; Minami M
    Eur J Radiol; 2011 Nov; 80(2):e91-7. PubMed ID: 20576386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
    Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
    Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
    Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
    J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic efficacy of multiple MRI parameters in differentiating benign vs. malignant thyroid nodules.
    Wang H; Wei R; Liu W; Chen Y; Song B
    BMC Med Imaging; 2018 Dec; 18(1):50. PubMed ID: 30509198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer.
    Ma FH; Cai SQ; Qiang JW; Zhao SH; Zhang GF; Rao YM
    J Magn Reson Imaging; 2015 Jul; 42(1):42-7. PubMed ID: 25176611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI Evaluation of Complex Ovarian Masses.
    Singla V; Dawadi K; Singh T; Prabhakar N; Srinivasan R; Suri V; Khandelwal N
    Curr Probl Diagn Radiol; 2021; 50(1):34-40. PubMed ID: 31399230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyogenic hepatic abscesses: MRI findings on T1- and T2-weighted and serial gadolinium-enhanced gradient-echo images.
    Balci NC; Semelka RC; Noone TC; Siegelman ES; de Beeck BO; Brown JJ; Lee MG
    J Magn Reson Imaging; 1999 Feb; 9(2):285-90. PubMed ID: 10077026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
    Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
    Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.